Stock Analiz

Nuvation Bio Inc. (NUVB) financials: revenue, earnings and cash flow

Fiscal 2020–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Net income in fiscal 2025 was -$205M, a net margin of -325.3%; the best year in this period was 2020 with -$42M.

Over the twelve months to September 30, 2026, revenue was $202M and net income -$136M.

Free cash flow was -$181M in fiscal 2025 and positive in 0 of the 6 years shown.

The diluted share count fell 100% over the period (buybacks).

Revenue, profit and cash flow by year

Revenue
2023: $020232024: $8M20242025: $63M2025$63M
Net income
2020: -$42M20202021: -$87M20212022: -$104M20222023: -$76M20232024: -$568M20242025: -$205M2025-$205M
EPS (diluted)
2020: $-0.4320202021: $-0.4420212022: $-0.4820222023: $-0.3520232024: $-2.1120242025: $-0.602025$-0.60

Income statement

Fiscal yearTTM202520242023202220212020
Revenue$202M$63M$8M$0———
Gross profit——$795000$0———
Operating income-$123M-$213M-$593M-$100M-$120M-$93M-$44M
Net income-$136M-$205M-$568M-$76M-$104M-$87M-$42M
EPS (diluted)$-0.40$-0.60$-2.11$-0.35$-0.48$-0.44$-0.43
R&D$133M$115M$99M$71M$88M$69M$33M
Revenue growth—+699.0%—————

Cash flow

Fiscal yearTTM202520242023202220212020
Operating cash flow-$106M-$173M-$130M-$68M-$96M-$68M-$37M
Capital spending$0-$8M$0————
Free cash flow-$106M-$181M-$130M————
Dividends paid—$0$0$0$0$0$0
Buybacks———————
Stock-based pay$38M$36M$32M$20M$16M$9M$2M

Balance sheet

Fiscal yearTTM202520242023202220212020
Cash—$529M$503M$611M$661M$765M$216M
Debt—$57M$9M$4M$4M$3M$4M
Equity—$306M$464M$605M$655M$746M$215M
Total assets—$595M$541M$621M$672M$776M$222M
Shares (diluted)352M342M269M219M217M198M97.53B

Margins and returns

Fiscal yearTTM202520242023202220212020
Gross margin——10.1%————
Operating margin-61.2%-338.7%-7527.3%————
Net margin-67.4%-325.3%-7213.8%————
FCF margin-52.6%-288.4%-1656.5%————
ROIC—-58.7%-125.4%-16.4%-18.2%-12.5%-19.9%
ROE—-66.9%-122.5%-12.5%-15.9%-11.6%-19.4%

Frequently asked questions

What is Nuvation Bio’s annual revenue?

$63M in fiscal 2025 and $202M over the twelve months to September 30, 2026.

How much profit does Nuvation Bio make?

Net income was -$205M in fiscal 2025 (net margin -325.3%).

Is Nuvation Bio’s revenue growing?

Yes: revenue rose 699.0% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.